Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

19 Countries Have Submitted Bids To Host The EMA Post-Brexit

Executive Summary

Formal offers to host the European Medicines Agency were received from 19 countries by the deadline of July 31. The European Commission will now begin assessing the bids on the basis of six criteria, with a final decision expected in November.

You may also be interested in...



Irish Brexit Event A Chance For Originator And Biosimilar Firms To Air Their Concerns

A stakeholder event being organized by the Irish regulatory body, the HPRA, will hear views on the implications and risks of Brexit from associations representing the originator and generic/biosimilar industries, as well as the head of the HPRA’s task force on Brexit.

In Austria, Industry Worries Over Loss Of EU Medtech NBs

EU member state Austria has lost its only two medtech notified bodies, which is ringing alarm bells for local medtech industry advocates who fear there will be a loss of momentum and profile for the national medtech ecosystem.

Bids For EMA Show East-West Split Over Principle of Fair Spread Of Agencies

Some countries in eastern Europe say that they should host the European Medicines Agency in order to respect the criterion of “geographical spread.” But many in western Europe say this principle should apply only to new agencies and that the criterion of business continuity at the EMA should take precedence.

Related Content

Topics

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel